Hypofractionated radiotherapy for refractory or relapsed aggressive B-cell lymphoma in the rituximab era

Abstract Background Radiotherapy (RT) is an effective and available local treatment for patients with refractory or relapsed (R/R) aggressive B-cell lymphomas. However, the value of hypofractionated RT in this setting has not been confirmed. Methods We retrospectively analyzed patients with R/R aggr...

Descrición completa

Detalles Bibliográficos

Principais autores:	Cheng Huang, Tian-Lan Tang, Yan-Yan Qiu, Yu-Ping Lin, Si-Lin Chen, Rui-Zhi Zhao, Gui-Qing Shi, Si-Qin Liao, Jin-Hua Chen, Hai-Ying Fu, Jian-Zhi Liu, Ben-Hua Xu, Ting-Bo Liu, Yong Yang
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMC 2024-01-01
Series:	BMC Cancer
Assuntos:	Radiotherapy Hypofractionated Refractory Relapsed B-cell lymphoma
Acceso en liña:	https://doi.org/10.1186/s12885-024-11837-2
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!